Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study (Q40070060)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study |
scientific article |
Statements
1 reference
Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study (English)
1 reference
Pierre Fenaux
1 reference
Lionel Adès
1 reference
Simone Boehrer
1 reference
Thorsten Braun
1 reference
Jennifer Grosjean
1 reference
Claire Fabre
1 reference
Génèviève Le Roux
1 reference
Claude Gardin
1 reference
Antoine Martin
1 reference
9 October 2007
1 reference
Identifiers
1 reference